+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
Raynauds Disease - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Raynauds Disease - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 99 Pages
  • Global
From
Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 213 Pages
  • Global
From
Heart Failure: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Heart Failure: Global Drug Forecast and Market Analysis to 2028

  • Report
  • December 2019
  • 190 Pages
  • Global
From
Heart Failure: Epidemiology Forecast to 2028 - Product Thumbnail Image

Heart Failure: Epidemiology Forecast to 2028

  • Report
  • December 2019
  • 63 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more